Kastus® launches a new generation of antimicrobial and antiviral screen protectors proven to block surface bacteria and human Coronavirus.Kastus® and Exertis announce Next Gen Tablet Touchscreen Partnership

Kastus® launches a new generation of antimicrobial and antiviral screen protectors proven to block surface bacteria and human Coronavirus.
Exertis Partnership Banner (3)

Kastus® and Exertis announce next-gen tablet touchscreen partnership

UK, DECEMBER 2019Touchscreens are an essential part of modern life whether using our   personal devices or interacting with self-service kiosks. When scientific studies show that smart phones carry 10 times more [1] bacteria than most toilets and are four times as many germs found on a self-service touchscreen than on a toilet seat[2], it’s no surprise that many consumers are concerned about engaging with touchscreen surfaces and being exposed to infectious germs such as MRSA, E. coli and C. diff.

Kastus® is on a mission to tackle the growing issue of harmful bacteria contagion and spread with its game-changing 24/7 antimicrobial touchscreen surface coating. A patented coating that’s applied during the glass manufacturing process, Kastus® is scientifically proven to block up to 99.99 percent of harmful bacteria, delivering ‘always on’ germ-free protection to shared touchscreens and personal devices, such as tablets and smartphones — for life.

In a recent consumer survey commissioned by Kastus®[3], over 70 percent of respondents stated they were worried about using public touchscreens. Bank ATMs caused the most concern among respondents, with doctor’s surgery and hospital check-in screens a close second. Fast food chain order screens, supermarket self-service tills and airport check-in kiosks were also identified as a concern. Of those surveyed, over 80 percent also stated they would actively seek out a business or establishment that offered a touchscreen with an invisible germ-free coating. These insights confirm the consumer desires and business opportunities that the latest Exertis tablet will address with their next gen Kastus-protected antimicrobial screens.

“Exertis is a company that we have hoped to collaborate with for some time; their tablet offering and focus on technological innovation makes for an ideal partnership. The team at Kastus® is looking forward to bringing added value and functionalities to Exertis’ product range, particularly where hygiene is a priority. We are excited by the possibilities that we can mutually create and look forward to working with Simon and his team.”

Exertis is the leading technology distributor of consumer, business and enterprise products from established and emerging technology brands, and a wholly owned subsidiary of parent company DCC PLC, a FTSE 100 company. 

Exertis represents 1,400 global and emerging brands selling to more than 50,000 reseller and retailer customers focused on consumer, mobile, business, enterprise and IT Supplies. It also provides an industry leading and innovative range of services and value-added solutions. With offices in Europe, North America, Middle East and China and with global reach via its supply chain services.

“We believe that this innovative partnership with Kastus® will increase our brand and product equity. Not only tangible, but intangible cocreated assets will help us to make many more signature offerings. Using Kastus® antimicrobial coating will not only enhance our product with high antimicrobial protection but also, it will enable us to provide solutions for our resellers in a number of vertical markets where hygiene is a critical factor,” said, Simon Woodman, Exertis, sales and commercial director, mobile."

[1] Dr Charles Gerba, University of Arizona.

[2] Dr Charles Gerba, University of Arizona.

[3] Research conducted by Trend-Monitor in June 2019, with a representative sample of 1000 UK consumers

Share on facebook
Facebook
Share on linkedin
LinkedIn
Share on twitter
Twitter
Share on email
Email
Share on whatsapp
WhatsApp